Ativo Capital Management’s Utah Medical Products UTMD Stock Holding History

Ativo Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,025	Closed	-$1.13M	–	180
2018 Q3	$1.13M	Hold	12,025	–	–	0.3%	136
2018 Q2	$1.32M	Sell	12,025 -5,501	-31%	-$574K	0.37%	92
2018 Q1	$1.73M	Hold	17,526	–	–	0.49%	44
2017 Q4	$1.43M	Buy	17,526 +1,001	+6%	+$78.1K	0.38%	92
2017 Q3	$1.22M	Hold	16,525	–	–	0.33%	133
2017 Q2	$1.2M	Hold	16,525	–	–	0.33%	132
2017 Q1	$1.03M	Hold	16,525	–	–	0.26%	158
2016 Q4	$1.2M	Hold	16,525	–	–	0.28%	126
2016 Q3	$988K	Buy	16,525 +1,700	+11%	+$108K	0.23%	150
2016 Q2	$934K	Buy	14,825 +6,300	+74%	+$406K	0.23%	135
2016 Q1	$533K	Hold	8,525	–	–	0.14%	129
2015 Q4	$499K	Buy	8,525 +265	+3%	+$15K	0.13%	157
2015 Q3	$473K	Hold	8,260	–	–	0.13%	182
2015 Q2	$443K	Buy	8,260 +888	+12%	+$50K	0.16%	167
2015 Q1	$441K	Hold	7,372	–	–	0.17%	150
2014 Q4	$443K	Hold	7,372	–	–	0.18%	168
2014 Q3	$359K	Buy	7,372 +300	+4%	+$15.2K	0.14%	158
2014 Q2	$364K	Hold	7,072	–	–	0.16%	150
2014 Q1	$409K	Hold	7,072	–	–	0.17%	148
2013 Q4	$404K	Hold	7,072	–	–	0.18%	148
2013 Q3	$420K	Sell	7,072 -946	-12%	-$51.6K	0.2%	119
2013 Q2	$435K	Buy	+8,018	New	+$377K	0.22%	78

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ativo Capital Management's UTMD Position: Q4 2018 in Review

Ativo Capital Management sold out of Utah Medical Products (UTMD) in Q4 2018, closing a stake of 12,025 shares — an estimated $1.13M sold.

Ativo Capital Management first reported a position in UTMD in Q2 2013 and held it in 22 quarters. The position peaked at $1.73M in Q1 2018. 88 funds tracked by Wall St. Rank hold UTMD as of Q4 2018.

Ativo Capital Management reported no remaining Utah Medical Products position as of Q4 2018 after selling out during the quarter.
Ativo Capital Management sold 12,025 Utah Medical Products shares in Q4 2018, an estimated $1.13M.
Ativo Capital Management first reported a position in Utah Medical Products in Q2 2013 and held it in 22 quarters.
Ativo Capital Management's Utah Medical Products position peaked at $1.73M in Q1 2018.
88 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2018.

Based on Ativo Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.